Trials / Completed
CompletedNCT04647539
Emerging Invasive Fungal Infections in Critically Ill Patients
Emerging Invasive Fungal Infections in Critically Ill Patients: Epidemiological Trends, Clinical Features and Outcomes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 26 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Rationale: Beside Candida and Aspergillus, emerging invasive fungal infections (EIFIs) are increasing in intensive care setting and are associated with high morbidity and mortality. However, data are scarce, particularly in ICU settings and for EIFIs other than mucormycosis. Objectives: to describe epidemiological trends and clinical features of EIFIs in intensive care units (ICU) and to assess their outcome. Methods: All records of adult patients diagnosed with an EIFI in a medical ICU between 2006 and 2019 were analyzed retrospectively. In-ICU mortality was assessed, then factors associated with mortality were identified. Survival at day-90 was calculated by the Kaplan-Meier method.
Conditions
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2019-12-01
- Completion
- 2020-11-23
- First posted
- 2020-12-01
- Last updated
- 2020-12-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04647539. Inclusion in this directory is not an endorsement.